These mutations destabilize the Keap1–Nrf2 interaction leading to Nrf2 protein stabilization and induced transcriptional responses that protect cancer cells from environmental stresses, including the potential toxicity of cancer drugs or radiation therapy [47], [48], [49]. This evidence concerns the gene NFE2L2 and cancer.